Digital Migraine Treatment Device Market Industry Research, Growth Trends and OpPosted by sachi kaushik on March 16th, 2021 The occurrence of spasmodic headache is termed as a medical condition called as migraine. The onset of migraine is generally experienced by approximately 15% of the world population. The symptoms include mild to severe headache and issues pertaining sensitivity to light and sound. For more insights into the Market, Request a Sample of this Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=3995 The expensive dependence on pharmaceutical drugs and therapies which are invasive, impeding with the implants, causing overuse and associated side effects. While the current treatments include triptans and ergots patients are shifting towards more specific digital migraine treatment devices. Neuromodulation is primarily the technology driving the patients towards the growth of the digital migraine treatment devices. The USFDA gave de novo clearance to Thranica’s Nevirio Migra, a smartphone connected device giving other manufacturers an aspiration to enter the untapped markets. Digital Migraine Treatment Device Market: Segmentation Tentatively, the global Digital Migraine Treatment Devices market can be segmented on the basis of the technology, end user, and geography. Based on the technology, the global digital migraine treatment devices market is segmented as:
Based on end user, the global digital migraine treatment devices market is segmented as:
Digital Migraine Treatment Device Market: Overview Based on the technology utilized, the digital migraine treatment devices have been segmented into supraorbital stimulation digital migraine treatment devices, Vagus nerve stimulation (VNS) digital migraine treatment devices, single-pulse transcranial magnetic stimulation digital migraine treatment devices and occipital nerve stimulation digital migraine treatment devices. Supraorbital stimulation digital migraine treatment devices are expected to hold the maximum revenue share in the digital migraine treatment devices market. Based on the end user, the digital migraine treatment devices market has been segmented into hospitals, specialty clinics and pharmacies. Hospitals are expected to hold the maximum revenue share in the digital migraine treatment devices market. Digital Migraine Treatment Device Market: Regional Outlook Geographically, the global digital migraine treatment devices market is segmented into seven regions viz. North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA. North America is expected to be a dominant market in the global digital migraine treatment devices market because of the presence of well-established healthcare infrastructure and availability of advanced healthcare facilities. The Asia Pacific is expected to hold a significant growth rate of digital migraine treatment devices market. The digital migraine treatment devices market in the Asia Pacific is expected to grow at a significant CAGR due to the presence of a large population. Europe is also expected to hold a large revenue share in the digital migraine treatment devices market owing to the increasing R&D funding and increasing healthcare awareness. Digital Migraine Treatment Devices Market: Key Players There are few key players operating in the digital migraine treatment devices market like Theranica Bio-Electronics LTD, electroCore, Inc., Cirrus Healthcare Products, Cefaly Technology, eNeura Inc., Prolivio and Neuros Medical. The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The report covers exhaustive analysis on:
Regional analysis includes
About Us: Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. Contact: US Sales Office: Like it? Share it! More by this author |